Our results showed that the patients in stages C and D of COVID-19 had significantly higher levels of PAI-1 and TAFI than those in stages A and B of the disease (p = 0.003 and p = 0.002, respectively) (Figure 3A,E). The gene discussed is SERPINE1; the disease is COVID-19.